Wockhardt Ltd. plunged the most in six months after its third drug-manufacturing plant in India was banned by the Food and Drug Administration from importing products into the U.S.
The FDA said in an alert posted Friday that it had banned all drugs and drug products made by the factory, based in Ankleshwar, India. The plant makes bulk ingredients according to Wockhardt’s annual report. The agency recently inspected the Ankleshwar facility and three others, the company said in the report, and Wockhardt had responded to those findings.
The FDA said in an alert posted Friday that it had banned all drugs and drug products made by the factory, based in Ankleshwar, India. The plant makes bulk ingredients according to Wockhardt’s annual report. The agency recently inspected the Ankleshwar facility and three others, the company said in the report, and Wockhardt had responded to those findings.
